KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Quest Diagnostics (DGX) Other Operating Expenses (2016 - 2026)

Quest Diagnostics' Other Operating Expenses history spans 18 years, with the latest figure at -$2.0 million for Q1 2026.

  • On a quarterly basis, Other Operating Expenses changed 0.0% to -$2.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was $12.0 million, a 1300.0% increase, with the full-year FY2025 number at $12.0 million, up 1300.0% from a year prior.
  • Other Operating Expenses hit -$2.0 million in Q1 2026 for Quest Diagnostics, down from $17.0 million in the prior quarter.
  • Over the last five years, Other Operating Expenses for DGX hit a ceiling of $20.0 million in Q2 2025 and a floor of -$35.0 million in Q4 2023.
  • Historically, Other Operating Expenses has averaged -$2.9 million across 5 years, with a median of -$2.0 million in 2024.
  • The widest YoY moves for Other Operating Expenses: up 600.0% in 2025, down 2200.0% in 2025.
  • Tracing DGX's Other Operating Expenses over 5 years: stood at -$21.0 million in 2022, then crashed by 66.67% to -$35.0 million in 2023, then surged by 117.14% to $6.0 million in 2024, then soared by 183.33% to $17.0 million in 2025, then crashed by 111.76% to -$2.0 million in 2026.
  • Business Quant data shows Other Operating Expenses for DGX at -$2.0 million in Q1 2026, $17.0 million in Q4 2025, and -$23.0 million in Q3 2025.